Stay updated with breaking news from Calcimedica. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CalciMedica, Inc. (NASDAQ:CALC – Get Rating)’s share price rose 0.3% on Monday . The company traded as high as $5.55 and last traded at $5.29. Approximately 14,644 shares traded hands during mid-day trading, an increase of 76% from the average daily volume of 8,312 shares. The stock had previously closed at $5.28. Wall Street Analyst […] ....
Results support the initiation of clinical studies to assess Orai1 inhibition in patients with recurrent acute pancreatitis (RAP) and early CP Data show. ....
Results support the initiation of clinical studies to assess Orai1 inhibition in patients with recurrent acute pancreatitis and early CP Data show that inhibiting Orai1-mediated store-operated Ca2+. | June 6, 2023 ....
CalciMedica (NASDAQ:CALC – Get Rating) is one of 995 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its rivals? We will compare CalciMedica to related businesses based on the strength of its profitability, risk, valuation, analyst recommendations, earnings, institutional ownership and dividends. Profitability This table compares CalciMedica and […] ....